Rixathon (Rituximab Vials) 500 mg/50ml

Rixathon (Rituximab) 500 mg/50ml vials are prescribed for certain autoimmune and cancer conditions. This biologic therapy targets CD20-positive B-cells for immune modulation. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance when using.

Strength

500 mg/50ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Sandoz

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rituximab is used to treat autoimmune disorders like rheumatoid arthritis and certain types of blood cancers such as non-Hodgkin lymphoma. It works by reducing specific immune cells to manage symptoms. Patients often ask, what is Rituximab used for in chronic conditions? The medication helps control inflammation and abnormal cell growth in approved indications.

Side Effects

Common effects include infusion-related reactions like fever or chills during administration. Some patients may experience fatigue or mild gastrointestinal discomfort. These effects are typically temporary and monitored during treatment sessions. Always report persistent symptoms to your healthcare provider.

Precautions & Warnings

Handle vials with care to avoid contamination or breakage. Keep refrigerated at 2-8°C and protect from light. Do not freeze or shake vigorously. Ensure proper disposal of used vials and needles according to local regulations. Always use under medical supervision.

Avoid Interactions

Rituximab may interact with other immunosuppressants or live vaccines, potentially increasing infection risk. Alcohol and certain medications like chemotherapy agents may heighten side effects. Discuss all current medications with your doctor before starting treatment. Monitor for unusual symptoms during combined therapies.

References

Frequently Asked Questions

Rituximab is prescribed for autoimmune diseases like rheumatoid arthritis and certain blood cancers such as non-Hodgkin lymphoma.

Rixathon is given as an intravenous infusion under medical supervision, typically in a clinical setting.

Common effects include infusion reactions like fever or chills, fatigue, and mild gastrointestinal discomfort.

Rituximab requires a prescription and should only be obtained through licensed pharmacies or healthcare providers.

Store vials refrigerated between 2-8°C and protect from light until ready for use.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.